Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
2016 | journal article???letter_note???. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
Mossner, M.; Jann, J.-C.; Nowak, D.; Platzbecker, U.; Giagounidis, A. A. N.; Goetze, K. & Letsch, A. et al. (2016)
Leukemia, 30(9) pp. 1956-1959. DOI: https://doi.org/10.1038/leu.2016.111
Documents & Media
Details
- Authors
- Mossner, Maximilian; Jann, J-C; Nowak, D.; Platzbecker, Uwe; Giagounidis, Aristoteles A. N.; Goetze, K.; Letsch, Anne; Haase, Detlef; Shirneshan, Katayoon; Braulke, Friederike; Schlenk, Richard F.; Haferlach, Torsten; Schafhausen, Philippe; Bug, G.; Luebbert, Michael; Ganser, Arnold; Buesche, Guntram; Schuler, E.; Nowak, V.; Pressler, Jovita; Oblaender, Julia; Fey, Stephanie; Mueller, N.; Lauinger-Loersch, E.; Metzgeroth, Georgia; Weiss, C.; Hofmann, W-K; Germing, U.; Nolte, F.
- Issue Date
- 2016
- Status
- published
- Publisher
- Nature Publishing Group
- Journal
- Leukemia
- ISSN
- 1476-5551; 0887-6924
